Literature DB >> 15340262

Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing.

Raffaele Palmirotta1, Sabino Matera, Maria Cristina Curia, Gitana Aceto, Bassam el Zhobi, Fabio Verginelli, Fiorella Guadagni, Vincenzo Casale, Vittoria Stigliano, Luca Messerini, Renato Mariani-Costantini, Pasquale Battista, Alessandro Cama.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is widely considered to be a syndrome of defective mismatch repair (MMR). A major concern with genetic diagnosis of HNPCC is the variable, often low, percentage of pathogenic germline mutations that can be detected in MMR genes using common screening methods. The variable percentage of mutation detected is in part related to the sensitivity of conventional screening methods and may also depend on the heterogeneous genetics of HNPCC. Thus, identification of phenotypic criteria predictive of germline mutations in MMR genes may be helpful in efficient HNPCC genetic testing. Clinical diagnostic criteria, initially developed for HNPCC (e.g., Amsterdam I and II, or Bethesda criteria), can be used to clinically select patient candidates that carry germline mutations in MMR genes. More useful criteria were previously developed by analyzing families with germline MMR mutations. Using a complementary approach based on tumor microsatellite instability analysis, we confirm that the Amsterdam criteria are significantly better than the Bethesda criteria in predicting families with MSI-H tumors (P = 0.0227). Our results also suggest that a cutoff at < 50 years' mean age at diagnosis of HNPCC-related cancers (especially colorectal and endometrial cancer) may be an additional tool for the identification of families with defective MMR. Recent advances in MMR mutation screening are expected to improve detection of pathogenic MMR mutations in these families. Conversely, the high proportion of MSS tumors observed in our series of families with advanced age at cancer diagnosis is consistent with the low percentage of MMR mutations detected by previous studies in families with this phenotype. These families probably carry mutations in other genes that may or may not be related to MMR. Additional studies are necessary to clarify the molecular basis for HNPCC in families with MSS tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15340262     DOI: 10.1023/B:FAME.0000039864.19083.3a

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  23 in total

1.  Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.

Authors:  R J Scott; M McPhillips; C J Meldrum; P E Fitzgerald; K Adams; A D Spigelman; D du Sart; K Tucker; J Kirk
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

2.  The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.

Authors:  T Liu; H Yan; S Kuismanen; A Percesepe; M L Bisgaard; M Pedroni; P Benatti; K W Kinzler; B Vogelstein; M Ponz de Leon; P Peltomäki; A Lindblom
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

3.  A role for MLH3 in hereditary nonpolyposis colorectal cancer.

Authors:  Y Wu; M J Berends; R H Sijmons; R G Mensink; E Verlind; K A Kooi; T van der Sluis; C Kempinga; A G van dDer Zee; H Hollema; C H Buys; J H Kleibeuker; R M Hofstra
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

4.  HNPCC associated with germline mutation in the TGF-beta type II receptor gene.

Authors:  S L Lu; M Kawabata; T Imamura; Y Akiyama; T Nomizu; K Miyazono; Y Yuasa
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

5.  MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.

Authors:  J Huang; S A Kuismanen; T Liu; R B Chadwick; C K Johnson; M W Stevens; S K Richards; J E Meek; X Gao; F A Wright; J P Mecklin; H J Järvinen; H Grönberg; M L Bisgaard; A Lindblom; P Peltomäki
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

Review 6.  Deficient DNA mismatch repair: a common etiologic factor for colon cancer.

Authors:  P Peltomäki
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

7.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

8.  Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.

Authors:  F M Richards; S A McKee; M H Rajpar; T R Cole; D G Evans; J A Jankowski; C McKeown; D S Sanders; E R Maher
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

9.  MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.

Authors:  Françoise Charbonnier; Sylviane Olschwang; Qing Wang; Cécile Boisson; Cosette Martin; Marie-Pierre Buisine; Alain Puisieux; Thierry Frebourg
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

Review 10.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

View more
  2 in total

1.  Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.

Authors:  Vittoria Stigliano; Daniela Assisi; Maurizio Cosimelli; Raffaele Palmirotta; Diana Giannarelli; Marcella Mottolese; Lupe Sanchez Mete; Raffaello Mancini; Vincenzo Casale
Journal:  J Exp Clin Cancer Res       Date:  2008-09-19

2.  Novel insulin receptor substrate 1 and 2 variants in breast and colorectal cancer.

Authors:  Diana Liberata Esposito; Fabio Verginelli; Sonia Toracchio; Sandra Mammarella; Laura De Lellis; Cinzia Vanni; Antonio Russo; Renato Mariani-Costantini; Alessandro Cama
Journal:  Oncol Rep       Date:  2013-07-18       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.